Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-23 4:30 pm Purchase | 2026-09-16 | 13G | NURIX THERAPEUTICS INC NRIX | Perceptive Advisors LLC | 5,536,629 5.300% | 5,536,629 (New Position) | Filing History |
| 2026-08-14 4:17 pm Sale | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group, LLC | 8,782,256 8.100% | -1,914,058 (-17.89%) | Filing History |
| 2026-08-14 4:07 pm Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Vestal Point Capital, LP | 8,050,000 7.800% | 1,550,000 (+23.85%) | Filing History |
| 2026-08-14 4:05 pm Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Rubric Capital Management LP | 7,227,778 6.960% | 7,227,778 (New Position) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | T. Rowe Price Associates, Inc. | 5,436,587 5.300% | 3,044,721 (+127.29%) | Filing History |
| 2026-08-14 08:36 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 7,736,455 7.450% | 1,391,211 (+21.93%) | Filing History |
| 2026-07-31 10:42 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Vanguard Capital Management | 5,202,025 5.030% | 5,202,025 (New Position) | Filing History |
| 2026-05-15 5:01 pm Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Vestal Point Capital, LP | 6,500,000 6.300% | 6,500,000 (New Position) | Filing History |
| 2026-05-15 08:45 am Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 6,345,244 6.170% | 845,244 (+15.37%) | Filing History |
| 2026-05-06 11:30 am Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 5,541,271 5.400% | 1,381,331 (+33.21%) | Filing History |
| 2026-04-24 9:28 pm Purchase | 2026-04-20 | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group, LLC | 10,696,314 9.900% | 3,726,007 (+53.46%) | Filing History |
| 2026-03-27 11:09 am Sale | 2026-03-13 | 13G | NURIX THERAPEUTICS INC NRIX | VANGUARD GROUP INC | 0 0.000% | -2,598,097 (Position Closed) | Filing History |
| 2026-02-17 4:16 pm Purchase | 2025-12-31 | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 7,527,996 7.200% | 776,431 (+11.50%) | Filing History |
| 2025-11-14 5:02 pm Sale | 2025-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | Commodore Capital LP | 3,780,055 4.900% | -69,945 (-1.82%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 4,159,940 4.100% | -4,627,597 (-52.66%) | Filing History |
| 2025-11-05 11:40 am Sale | 2025-09-30 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 8,787,537 11.500% | -1,458,674 (-14.24%) | Filing History |
| 2025-05-15 08:44 am Purchase | 2025-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 5,500,000 7.210% | 1,375,000 (+33.33%) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Wellington Management Group LLP | 3,188,742 4.200% | -293,363 (-8.42%) | Filing History |
| 2025-05-12 10:36 am Sale | 2025-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | FMR LLC | 10,246,211 13.400% | -60,140 (-0.58%) | Filing History |
| 2025-04-23 8:57 pm Purchase | 2025-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | BlackRock Inc. BLK | 6,284,116 8.200% | 241,966 (+4.00%) | Filing History |